RECOVERY-01 · Protocol
Member - $149/mo, medication included when prescribed
Requires an online consultation with a licensed provider.
Important safety information
A recovery protocol built around clinical review, relevant baseline markers, and a sober read of what a growth-hormone-releasing peptide can and cannot promise.
Signs + Readout
Shallower sleep, longer soreness, and a training log that moves more slowly are real observations. They are not a diagnosis of growth hormone deficiency.
A provider may use IGF-1 as part of the context because a random growth hormone draw is hard to interpret. The marker supports a conversation. It does not promise an outcome.
Baseline and follow-up timing belong to the provider and the final protocol. No operational cadence is promised here.
What's included
Health history, recovery goals, current medications, and state routing.
Provider consultation · $20-35 pass-through. A licensed provider decides whether a growth-hormone-releasing peptide fits the clinical context.
Medication included when prescribed in the Member · $149/mo tier.
Labs · about $280 at cost. Relevant baseline markers may include IGF-1, chosen by the provider.
Follow-up and lab cadence come from the provider and the final operating protocol, not a date invented on this page.
How it works
Proof and legitimacy
A licensed provider in the patient’s state owns the decision. A listed form is not a guarantee of a prescription.
Sermorelin is not presented as HGH, a physique shortcut, or a promised recovery result.
Member · $149/mo, Labs · about $280 at cost, and Provider consultation · $20-35 pass-through. Medication is included when prescribed.
Injection and troche are separate live catalog forms. The provider decides whether either is appropriate.
Important safety information
The former FDA-approved Geref product is no longer marketed, and the products listed here are compounded. A provider and dispensing pharmacy must review the preparation-specific risks, interactions, and instructions.
Sources: FDA Pharmacy Compounding Advisory Committee materials; FDA Geref regulatory record; FDA clinical pharmacology review referencing the Geref label. Final clinical guidance comes from the current dispensed-product label, pharmacy, and provider.
This is a compounded product and has not been approved by the FDA. The FDA does not verify the safety or effectiveness of compounded drugs.
First month receipt
Medication included when prescribed.
Requires an online consultation with a licensed provider. Important safety information
This is a compounded product and has not been approved by the FDA. The FDA does not verify the safety or effectiveness of compounded drugs.
A troche form shown as its own product option.
Requires an online consultation with a licensed provider.
This is a compounded product and has not been approved by the FDA. The FDA does not verify the safety or effectiveness of compounded drugs.
An injectable option for a provider-guided recovery conversation.
Requires an online consultation with a licensed provider.
This is a compounded product and has not been approved by the FDA. The FDA does not verify the safety or effectiveness of compounded drugs.
A planned injectable listing, held clearly in the soon state.
Requires an online consultation with a licensed provider.
This is a compounded product and has not been approved by the FDA. The FDA does not verify the safety or effectiveness of compounded drugs.
Read before deciding
Sermorelin FAQ
Informational, not medical advice. A licensed provider in your state makes the call once they have seen your labs.
No. Sermorelin is a growth-hormone-releasing hormone analog. It stimulates pituitary growth hormone release rather than supplying recombinant human growth hormone. That distinction does not make it appropriate for everyone.
No outcome is guaranteed. The evidence does not support selling compounded sermorelin as a physique shortcut. A provider can discuss what the evidence does and does not establish.
Both are live catalog forms. Route, fit, and whether to prescribe at all belong to the provider after intake and review.
This page lists the products in the current data layer. It does not use forum popularity as a reason to add a compound or imply that a pharmacy can dispense one.
Yes. Every prescription requires an online consultation with a licensed provider, and the compounded-drug disclaimer applies to both listed forms.
Labs · about $280 at cost, Provider consultation · $20-35 pass-through, and Member · $149/mo. The estimated subtotal is printed in the receipt before intake.
Your next useful step
Share your recovery goals, history, and existing labs. A licensed provider decides whether sermorelin belongs in the conversation. Read the peptides wiki first if you want the mechanism.
Start Sermorelin intakeRequires an online consultation with a licensed provider. Important safety information